Cover Image

Combined Oral Contraceptives for Polycystic Ovary Syndrome: <i>Pro</i> and <i>Contra</i> (Review)

INTRODUCTION. Polycystic ovary syndrome (PCOS) is the main cause of female infertility. Clinical practice guidelines on PCOS recommend combined oral contraceptives (COCs) as first-line therapy. Given the association of PCOS with a number of clinical conditions, including obesity, type 2 diabetes mel...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. A. Mazerkina (Author), I. G. Davydov (Author), O. S. Alyautdina (Author)
Format:	Book
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME
by: M. A. Gevorkyan, et al.
Published: (2016)

Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives
by: Nicolás Santander, et al.
Published: (2024)

Combined oral contraceptives: evolution of the relationship benefit/risk
by: O. S. Alyautdina
Published: (2018)

Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
by: Chan-Hong Park, et al.
Published: (2020)

<i>In Vitro</i> Assessment of Drug-Induced Liver Injury Using Cell-Based Models: A Review
by: I. A. Mazerkina
Published: (2023)

Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
by: Sebastião Freitas de Medeiros
Published: (2017)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
by: Yang YM, et al.
Published: (2015)

Antioxidative Effects of Standardized <i>Aronia melanocarpa</i> Extract on Reproductive and Metabolic Disturbances in a Rat Model of Polycystic Ovary Syndrome
by: Jovan Rudic, et al.
Published: (2022)

A meta-analysis of the association of ApaI, BsmI, FokI, and TaqI polymorphisms in the vitamin D receptor gene with the risk of polycystic ovary syndrome in the Eastern Mediterranean Regional Office population
by: Arvin Shahmoradi, et al.
Published: (2022)

Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study
by: Betânia Rodrigues Santos, et al.
Published: (2018)

Association between <it>ACE </it>gene I/D polymorphisms and hyperandrogenism in women with Polycystic Ovary Syndrome (PCOS) and controls
by: Liang Fengjing, et al.
Published: (2009)

Combined Oral Contraceptive Effects on Low-Grade Chronic Inflammatory Mediators in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
by: Sebastião Freitas de Medeiros, et al.
Published: (2018)

Effect of drospirenone-containing combined oral contraceptive pills on anthropometric and sonographic characteristics and carbohydrate metabolism parameters in women with polycystic ovary syndrome
by: L.V. Saprykina, et al.
Published: (2022)

Association of BsmI variant of vitamin D receptor gene with polycystic ovary syndrome: A case-control study
by: Nasim Ramezani, et al.
Published: (2020)

Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
by: Soo Jin Han, et al.
Published: (2024)

Levels of Some Pro-inflammatory Cytokines in Pregnant Women with Polycystic Ovary Syndrome
by: Mohammed A. Taher, et al.
Published: (2012)

The Immunosuppressive Properties of Cyclo-[<i>D</i>-Pro-Pro-<i>β</i><sup>3</sup>-HoPhe-Phe-] Tetrapeptide Selected from Stereochemical Variants of Cyclo-[Pro-Pro-<i>β</i><sup>3</sup>-HoPhe-Phe-] Peptide
by: Krzysztof Kaczmarek, et al.
Published: (2024)

O emprego dos contraceptivos orais combinados na síndrome dos ovários policísticos The use of combined oral contraceptives in the polycystic ovary syndrome
by: José Maria Soares Júnior, et al.
Published: (2010)

Primary <i>Burkitt′s lymphoma</i> of the ovary
by: Cyriac Sanju, et al.
Published: (2010)

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
by: de Melo AS, et al.
Published: (2017)

Specificities of the treatment for polycystic ovary syndrome and metabolic syndrome
by: I.Yu. Ilina
Published: (2020)

Polycystic Ovary Syndrome
Published: (2012)

Current trends in surgical treatment for infertility associated with polycystic ovary syndrome
by: I.I. Grishin, et al.
Published: (2022)

Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception
by: T Iu Pestrikova, et al.
Published: (2016)

Cholelithiasis ascomorbidity polycystic ovary syndrome disease
by: Yu B Uspenskaya, et al.
Published: (2015)

Effect of <i>Sechium edule</i> var. <i>nigrum spinosum</i> (Chayote) on Oxidative Stress and Pro-Inflammatory Markers in Older Adults with Metabolic Syndrome: An Exploratory Study
by: Juana Rosado-Pérez, et al.
Published: (2019)

Polycystic ovary syndrome and pregnancy - review
by: Magdalena Grześk-Kaczyńska, et al.
Published: (2022)

Polycystic ovary syndrome: the competence of a family doctor
by: V.V. Artyomenko, et al.
Published: (2023)

Acupuncture combined with Chinese and western medicine in the treatment of polycystic ovary syndrome
by: Xiao-Tao Huang, et al.
Published: (2020)

Acknowledgment to the Reviewers of <i>Oral</i> in 2022
by: Oral Editorial Office
Published: (2023)

Acknowledgment to Reviewers of <i>Oral</i> in 2021
by: Oral Editorial Office
Published: (2022)

Quercetin and polycystic ovary syndrome
by: Congshun Ma, et al.
Published: (2022)

Antitumor effects of vitamin B12 <i>in vitro</i>, <i>in vivo</i>, <i>in silico</i>
by: O. A. Gromova, et al.
Published: (2023)

New biomarkers for diagnosis of polycystic ovary syndrome
by: Farid I Hassan, et al.
Published: (2023)

Perceived Stress Scale Among Adolescents with Polycystic Ovary Syndrome
by: Khafagy G, et al.
Published: (2020)

Hyperuricemia and Pro Inflammatory Cytokine (IL-1Î², IL-6, and TNF-Î±)
by: Suyanto Hadi, et al.
Published: (2018)

<i>Sturge-<i>Weber syndrome</i></i>: A case report
by: Mukhopadhyay S
Published: (2008)

Polycystic Ovary Syndrome Functional Investigation and Clinical Application
Published: (2022)

Phytotherapy of polycystic ovary syndrome: A review
by: Farahnaz Azin, et al.
Published: (2022)

Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials
by: Hussain H. Almalki, et al.
Published: (2020)